Clinical trial · Observational
Remote Monitoring of Cancer Patients With Outpatient Treatment
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project focuses on studying the use of digital platforms for monitoring, between medical visits, parameters such as toxicities and therapeutic adherence. The goal of this observational study is to know the degree of usability of the Caaring® digital platform in cancer patients undergoing outpatient oral treatment. This will allow in the future to design comparative studies that demonstrate the advantages of using this application in the management of these patients. Participants will fill out various questionnaires in the Caaring app related to their symptoms, adherence to treatment, quality of life and physical activity, among others.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Patients With Outpatient Treatment | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Usability of Caaring® for the management of oncology patients in outpatient oral treatment
- timeFrame
- Day 0 up to 3 months
- description
- Percentage of patients with at least 80% of the data completed in the application, Percentage of patients with 100% of the data completed in the application and Percentage of completion per patient
Secondary outcomes (5)
- measure
- Degree of completion of data relating to treatment adherence
- timeFrame
- Weekly up to 3 months
- description
- The Degree of completion of therapeutic adherence by patients in Caaring application between visits is defined as the ratio between the questionnaires requested and completed.
- measure
- Degree of completion of data related to the toxicity of their treatment
- timeFrame
- Weekly up to 3 months
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Cancer patients with adjuvant or metastatic oncological treatment * Cancer patients with oral oncological treatment * Patients who are able to complete the study questionnaires * Patients who are able to handle the application on a smart mobile phone. * Informed consent is obtained from the patient. Exclusion Criteria: * Patients who will not be able to commit to carrying out the follow-ups or do not have adequate technological skills. * Patients with inability to give adequately the informed consent.
References
Publications (0)
Data not yet available